Tuesday, August 14, 2012

Exclusive Interview with Judges Paul Michel and Roger Hughes

PODCAST
Complimentary Podcast
LES Speakers' Corner:
Interviews with Judges Roger Hughes and Paul Michel & Annual Meeting Chairs
 

Get a sneak peek of the Annual Meeting with our new podcast series!

Episode 1: Interview with the Meeting Chairs
Tune into episode one where meeting chairs Tim Lowman and Gary Fedorochko talk about the meeting highlights, new features and what attendees can expect.

Listen Now

Episode 2: Preview of "Benches Unleashed: Judicial Views on Fixing the Systems"
Plenary Session Moderator Brian O'Shaughnessy sits down with Honourable Judge Roger Hughes of the Federal Court of Canada and Honorable Paul Michel, Retired Chief Judge of the US Court of Appeals for the Federal Circuit, to preview their Wednesday morning Plenary Session.

Listen Now

Don't miss the Annual Meeting, October 14-17 in Toronto. View the agenda and register now!

  LES Annual Meeting - October 14-17 in Toronto

Register Now

 
Toronto Skyline
© 2012 Licensing Executives Society (USA & Canada), Inc.

Forward email

This email was sent to seth.t.chase@gmail.com by lesmeetings@les.org |  

LES (USA & Canada) | 1800 Diagonal Road | Suite 280 | Alexandria | VA | 22314

Friday, August 10, 2012

Prepare for the CLP Exam

EEheader_FINAL
             
  Take the Next Step in Your Career and Earn the CLP Credential!  
             
 

Now LES Offers Two Ways to Prepare for the Exam!

CLP EXAM REVIEW COURSE
September 11, 2012
Offices of Woodcock Washburn
Philadelphia, PA

LES is offering a one-day review course on Tuesday, September 11 to help professionals prepare for the CLP exam. Taught by experienced CLP-certified LES members, the emphasis of the course is on the eight CLP domains, the practice exam questions and the participants' results. The one-day review also includes access to our new Virtual Knowledge Community, providing another opportunity for participants to review the domains and to ask questions of the LES experts. Of those who have taken this review course and the exam, 80% passed.

Introducing our New Virtual CLP Exam Review Course!
Can't attend our one-day review? Our new Virtual CLP Exam Knowledge Community will provide you with the tools and resources to create your own exam preparation experience. Gain access to over 12 hours of content preparation, collaborative groups, interactive quizzes, discussion forums, and expert faculty q&a from your desktop. Our September attendees will receive automatic access to this course upon registration.

INSTRUCTORS
Brian O'Shaughnessy, Shareholder, Buchanan Ingersoll & Rooney, PC
Susan Stoddard, Senior Licensing Manager, Mayo ClinicHealth Solutions
Scott Williams, Director, Intovex Group

CLE & CPE
The CLP Prep Course is eligible for 7.0 CLE credits and 9.0 CPE credits.

REGISTRATION FEES

$995 One-day Review Course and Virtual Knowledge Community Access
$750Virtual Knowledge Community Access Only

Register Now

     

CLP

Apply to Take the Certified
Licensing Professional (CLP) Exam during the October 2012 Window

Make 2012 the year you earn the Certified Licensing Professional (CLP) credential by applying to take the exam in October. Click here to start your application today. 

Earning the CLP credential fulfills your personal and professional goals by:

  • Establishing your credibility
  • Recognizing your expertise in the licensing industry
  • Showing you utilize the latest industry practices
  • Demonstrating your commitment to continuing education and professional development
  • Opening up job opportunities

Don't let this opportunity to become a Certified Licensing Professional (CLP) pass. Apply to take the exam in October today. 

 
             
   
             
 

What are industry leaders saying about the CLP? 

"Earning and maintaining your designation as a Certified Licensing Professional will distinguish you in the licensing industry as someone with experience and knowledge. Our office now requires that new senior licensing associates be CLP-certified or eligible to take the exam."

- Wes Blakeslee, CLP, Executive Director, Johns Hopkins Technology Transfer at Johns Hopkins University

"At Merck we embrace the CLP designation as a mark of distinction. We already have 12 Certified Licensing Professionals at Merck and we expect to increase this number significantly over time." 

-Barbara Yanni, CLP, Vice President and Chief Licensing Officer, Merck & Co., Inc.

 
EEfooter_FINAL
 
© 2012 Licensing Executives Society (U.S.A. and Canada), Inc. All rights reserved

Forward email

This email was sent to seth.t.chase@gmail.com by mail@les.org |  

LES (USA & Canada) | 1800 Diagonal Road | Suite 280 | Alexandria | VA | 22314

Thursday, August 2, 2012

8/8 Webinar - Case Study in Lanham Act Damages Calculations

Licensing Executives Society (U.S.A. and Canada)
             
 

Hear a Litigator and Damages Expert Discuss Their Experiences Establishing and Challenging Injury and Damages

 

LESSONS FROM THE JUICE WARS: CASE STUDY IN LANHAM ACT DAMAGES CALCULATIONS
Wednesday, August 8, 2012
1 PM EST / Noon CST / 11 AM MST / 10 AM PST (90 Minutes)

The Lanham Act affords considerable flexibility to successful plaintiffs in establishing injury and calculating damages, both in trademark infringement and false advertising cases. Courts recognize that determining the extent of lost profits and other harms from trademark or advertising violations is challenging, and will award damages based on fairly imprecise estimates. Nevertheless, the law requires that damages claims not be overly uncertain or speculative, and the plaintiff must prove by a preponderance of the evidence that it has been or is likely to be injured. These issues have played out recently in a prominent group of advertising cases centered on pomegranate juice. A litigator and damages expert involved in the cases explain the liability issues and how the various parties set out to establish or challenge injury and damages, with varying degrees of success.

SPEAKERS
Thomas Britven, Managing Director, Duff & Phelps
August Horvath, Partner, Kelley Drye 

CLE
This program is approved by the California and Illinois bar associations for 1.5 hours of self-study CLE credit. Other states may recognize similar credit hours.

Register Now

     

Upcoming Topics

 

American Invents Act: One year later - What now?
September 12, 2012

Patents: Avoiding Antitrust Litigation and Use of Surveys
October 10, 2012

Interested in having your team members join you on the webinar? The LES Webinar Company Subscription will allow you to add additional listeners at a reduced price.

 
 
Upcoming Courses
 

CLP Review Course
September 11, 2012
Philadelphia, PA

LES 2012 Annual Meeting
October 14-17, 2012
Toronto, ON

Best Practices in Licensing: Developing, Negotiating & Executing Transactions
November 13, 2012
Houston, TX

 
 
FacebookLinkedInTwitterYouTube
 
             
 
© 2012 Licensing Executives Society (U.S.A. and Canada), Inc. All rights reserved

Forward email

This email was sent to seth.t.chase@gmail.com by mail@les.org |  

LES (USA & Canada) | 1800 Diagonal Road | Suite 280 | Alexandria | VA | 22314

Tuesday, July 31, 2012

See Who's Attending the Annual Meeting - Last Day for Best Rate

 LES (USA & Canada) 2012 Annual Meeting - October 14-17 / Toronto
 
Register |View the Agenda |Event Home |Join LES
-------
 
This is your last chance to get the best registration rate for the Annual Meeting. The $200 Super Early discount expires today!
 

register-now-button-source

 
-------
 
JOIN THIS GROWING LIST OF PARTICIPANTS:
 

(This is a partial list of confirmed attendees)

  • CEO, Acacia Research Group
  • VP, Business Development, Allied Security Trust
  • Deputy Director of Commercialization, ARPA-E
  • VP, Business Development, Athena Diagnostics, Inc.
  • Director, Technology Commercialization, Battelle/Pacific Northwest National Lab
  • Assistant General Counsel, IP, Baxter Healthcare Corporation
  • Head, Business Development & Licensing, Bayer Animal Health
  • IP Manager, Baylis Medical Company
  • Director, Technology Licensing & Collaboration, BD Technologies
  • Director of Corporate Alliances and Tech Transfer, Bigelow Lab for Ocean Sciences
  • VP Compliance and IP, BIOAMBER INC.
  • Director, Consumer Products Licensing, The Boeing Company
  • Expert, Product Development and IP, Bombardier Transportation Canada
  • Director of Licensing, BOSE Corporation
  • Senior Officer, IP and Technology Transfer, Canadian Space Agency
  • Senior Officer, Property Management & Technology Transfer, Canadian Space Agency
  • Senior Manager, Research Division External Affairs, Chugai Pharmaceutical Co., Ltd.
  • Director, Technology Tranfer, Colorado School of Mines
  • President, Compact Membrane Systems, Inc.
  • VP of Business & Corporate Development, CoNCERT Pharmaceuticals, Inc.
  • Director of Global Business Development, Cook Biotech Incorporated
  • Analyst, Davenport & Co.
  • Senior Director, Licensing, Digimarc Corporation
  • EVP Corporate Development, DIGNA Biotech
  • Global Business Development, Eli Lilly and Company
  • VP, Corporate Business Development, Eli Lilly and Company
  • Licensing Director and Executive Counselor, GE Japan Corporation
  • Associate VP , Tech Transfer & Economic Development, Georgia Health Sciences University
  • Fund Advisor, Healthcare Royalty Partners
  • Editor in Chief, IAM Magazine
  • CEO, IGPC Ethanol Inc.
  • Director- IP Licensing, Audits & Collections, IGT - International Game Technology
  • Director IP, Immatics Biotechnologies GmbH
  • Licensing Manager, Innovate Calgary
  • Vice-President, Corporate Affairs, INO
  • General Manager, Inovent Corp
  • VP, Licensing, Intellectual Ventures
  • Director Business Development, Janssen Inc.
  • Manager, IP Market Transactions, John Deere
  • Sr. Director, Business Development, J&J Consumer Products
  • Sr. VP, Oncology, Kantar Health
  • Head of IP Management, Karlsruhe Institute of Technology
  • Senior License Manager, Karlsruhe Institute of Technology
  • Director, Business Development, Kowa Research Institute
  • Business Development Executive, Lawrence Livermore National Laboratory
  • Director, Industrial Partnerships, Lawrence Livermore National Laboratory
  • Associate Director, Lehigh University
  • Director, Innovation Implementation Services, Masco Corporation Research & Development
  • Technology Licensing Manager, Mayo Clinic
  • Senior Technology Licensing Manager, Mayo Clinic
  • Executive Director, Corporate Licensing, Merck & Co., Inc.
  • Associate Director Technology Transfer, Montana State University
  • GC & Corporate Secretary, MOSAID Technologies 
  • VP Business Development & Licensing, Myriad Genetic Laboratories, Inc.
  • Director, Tech Transfer Office, National Human Genome Research Institute (NHGRI), NIH
  • Technology Transfer Agent, National Security Agency
  • Licensing Associate, NDSU Research Foundation
  • Director, Patents & Licensing/Business Development, New York Blood Center & L.F.K. Research Institute
  • Licensing Manager, Northrop Grumman Corporation
  • Corporate Officer and Head, Business Development and Licensing, Novartis Pharma K.K.
  • Professor, Okayama University
  • VP, OSU Technology Commercialization & Knowledge Transfer
  • Principal, PanOptis IP, LLC
  • Manager, Corporate Development & Legal Affairs, Plentyoffish Media Inc.
  • President, PLX Pharma Inc.
  • Head of IP, Porsche
  • Open Innovation Leader, Global Business Development, Procter & Gamble
  • Director, IP Management & Business Development, Public Health Agency of Canada
  • Head of IP Exploitation, QinetiQ Ltd
  • Senior VP, Business Development & Commercial Operations, QLT Inc.
  • Licensing Manager, Raytheon Company
  • Vice President, Rheonix, Inc.
  • Director, IP and Tech Transfer, Rochester Institute of Technology
  • Senior Director, IP Management, Rockwell Collins, Inc.
  • Licensing Executive, Sandia National Laboratories
  • Business Development/Technology Transfer, Sandia National Laboratories
  • IP Counsel, SAP Canada
  • Head of Corp Development & Planning, SAS
  • Senior Associate, Stanford University
  • VP, Licensing and IP, Targacept, Inc.
  • Sr. Dir. Intellectual Asset Management, TeleCommunication Systems
  • Business Development, The Boeing Company
  • Associate VP, Office of Technology Transer, The Rockefeller University
  • IP Counsel, Titan Medical Inc.
  • Senior Associate Director, Office for Technology Licensing, Tufts University
  • Executive Director, Tulane University
  • Director, Technology Management, University Hospitals Case Medical Center
  • Licensing Manager, University of Iowa
  • Associate Vice Chancellor, Office of Technology Management, University of Pittsburgh
  • Industry Liaison Officer, University of Victoria
  • VP Business Development, Valent BioSciences Corporation
  • Licensing Manager, Corporate Product Innovation, Virbac
  • Executive Director, Virginia Commonwealth University
  • President, Virginia Tech Intellectual Properties, Inc.
  • Director, Technology Licensing, Weyerhaeuser NR Company
  • Director, Business Development -- IP, Woodward
  • VP Business Development, YM BioSciences Inc.
 
-------
 
Gold Sponsors 
CRA Finnegan Microsoft
 
Silver Sponsors
Bracewell Chipworks Global IP Law Group
ktMINE merck_silver P&G
RoyaltyStat Thomson Reuters
 
Bronze Sponsors
Acacia Brinks B&T Buchanan Dialog
G&B HTS Innography Kenyon Nix Patterson
pwc Questel. Robic TechInsights  
 
Event Sponsors
   
Lunch Sponsor High Tech Reception Life Science Reception
sponsored in part by
LESI Delegates Reception
NERA WiLAN Healthcare Royalty Partners Kirkland & Ellis
 
-------
 
Media Partners & Supporting Organizations
Official Strategic Media Partner

IAM
AUTM BioCentury BIO CHLA
CLP FICPI FLC IPFrontline
IP Magazine MIP TechConnect WIPR
       

© Licensing Executives Society (U.S.A. & Canada), Inc.

Forward email

This email was sent to seth.t.chase@gmail.com by lesmeetings@les.org |  

LES (USA & Canada) | 1800 Diagonal Road | Suite 280 | Alexandria | VA | 22314